Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. (Q31987662)

5 July 2017

title

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. (English)

1 reference

5 July 2017

0 references

1 reference

Fontana RJ

1 reference

5 July 2017

Moyer CA

1 reference

5 July 2017

Sonnad S

1 reference

5 July 2017

Lok ASF

1 reference

5 July 2017

Sneed-Pee N

1 reference

5 July 2017

Walsh J

1 reference

5 July 2017

Klein S

1 reference

5 July 2017

Webster S

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

The American Journal of Gastroenterology

5 July 2017

published in

1 reference

5 July 2017

1 reference

5 July 2017

1 reference

5 July 2017

page(s)

170-178

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Psychiatric symptoms in polysubstance abusers: relationship to race, sex, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Detecting alcoholism. The CAGE questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

A comparison of reverse transcription-polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Measuring health-related quality of life in patients with upper gastrointestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Hepatitis C virus and depression in drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

Physicians' assessments of the utility of health states associated with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03473.X

10.1111/J.1572-0241.2001.03473.X

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference